India: CCI Approves GlaxoSmithKline's Restructuring

Published on Aug 6, 2022

AZB & Partners recently represented GlaxoSmithKline Plc (‘GSK’) in securing a timely approval from the Competition Commission of India for the proposed restructuring of its consumer healthcare joint venture with Pfizer Inc. into the newly incorporated entity Haleon Plc, proposed to be listed in the UK, post the proposed demerger.

The team comprised our Partner Hemangini Dadwal, Senior Associate Nikita Agarwal, and Associate Varun Thakur, with special thanks to our Founding Partner Ajay Bahl and Senior Partners Samir R. Gandhi and Vinati Kastia Kilambi for their guidance.